What is the maximum dose of methyldopa for an adult (including oral and intravenous routes)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Methyldopa

The maximum recommended daily dose of methyldopa for adults is 3 grams (3000 mg) per day, administered orally in divided doses. 1

Oral Dosing

According to the FDA-approved labeling, the dosing parameters for methyldopa are:

  • Starting dose: 250 mg two to three times daily (750 mg/day total)
  • Usual maintenance dose: 500 mg to 2 grams daily in two to four divided doses
  • Maximum dose: 3 grams daily 1

The 2017 ACC/AHA hypertension guidelines list methyldopa with a usual dose range of 250-1000 mg twice daily, consistent with the FDA labeling 2, 3. The 2003 European guidelines on cardiovascular disease management during pregnancy specify methyldopa dosing as 750 mg to 4 grams per day in three or four divided doses 4, though this upper limit exceeds the FDA-approved maximum.

Important Dosing Considerations:

  • Dose titration: Increases should occur at intervals of not less than 2 days 1
  • Evening dosing: Start dose increases in the evening to minimize sedation 1
  • Renal impairment: Patients with impaired renal function may respond to smaller doses, as methyldopa is largely excreted by the kidney 1
  • Elderly patients: Lower doses may be needed to avoid syncope related to increased sensitivity and arteriosclerotic vascular disease 1
  • Pediatric patients: Maximum dose is 65 mg/kg or 3 grams daily, whichever is less 1

Intravenous Dosing

Methyldopa does not have an approved intravenous formulation. The 2017 ACC/AHA guidelines for hypertensive emergencies do not include methyldopa among the recommended intravenous antihypertensive agents 5, 6, 5. For acute hypertensive situations requiring IV therapy, other agents such as labetalol, nicardipine, or hydralazine are preferred.

Clinical Context:

While methyldopa effectively lowers blood pressure by approximately 13/8 mmHg compared to placebo 7, its delayed onset of action (blood pressure begins to decrease within 10-30 minutes after oral administration, with peak effects at 1 hour) 1, 8 makes it unsuitable for hypertensive emergencies. Recent PBPK-PD modeling suggests that due to this delayed onset, methyldopa should be combined with other antihypertensives during the first 48 hours when rapid blood pressure control is needed 9.

Common pitfall: Do not exceed 3 grams daily in adults, as higher doses have not shown additional benefit and the maximum recommended dose is well-established in FDA labeling 1.

References

Research

Methyldopa for primary hypertension.

The Cochrane database of systematic reviews, 2009

Research

Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.

Drug metabolism and disposition: the biological fate of chemicals, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.